Results 1 to 10 of about 46,055 (312)

Infant protection from invasive Haemophilus influenzae type b disease using the PRP-OMPC conjugate vaccine: An update

open access: goldHuman Vaccines & Immunotherapeutics
Invasive disease caused by Haemophilus influenzae type b (Hib) is a major health concern, particularly in children under 5 years of age and vulnerable populations.
Muhamed-Kheir Taha   +5 more
doaj   +2 more sources

Exploring the variables influencing the immune response of traditional and innovative glycoconjugate vaccines

open access: yesFrontiers in Molecular Biosciences, 2023
Vaccines are cost-effective tools for reducing morbidity and mortality caused by infectious diseases. The rapid evolution of pneumococcal conjugate vaccines, the introduction of tetravalent meningococcal conjugate vaccines, mass vaccination campaigns in ...
Francesca Micoli   +4 more
doaj   +1 more source

Vaccines against Meningococcal Diseases

open access: yesMicroorganisms, 2020
Neisseria meningitidis is the main cause of meningitis and sepsis, potentially life-threatening conditions. Thanks to advancements in vaccine development, vaccines are now available for five out of six meningococcal disease-causing serogroups (A, B, C, W,
Mariagrazia Pizza   +2 more
doaj   +1 more source

Vaccine hesitancy and receipt of mandatory and optional pediatric vaccines in Shanghai, China

open access: yesHuman Vaccines & Immunotherapeutics, 2022
Given increased global concern about vaccine hesitancy, this study estimates coverage of mandatory vs non-mandatory vaccines in children, and assesses whether vaccine hesitancy among young parents relates to their childʻs eventual vaccination status in ...
Mengdi Ji   +3 more
doaj   +1 more source

Protein-protein conjugation enhances the immunogenicity of SARS-CoV-2 receptor-binding domain (RBD) vaccines

open access: yesiScience, 2022
Summary: Several effective SARS-CoV-2 vaccines have been developed using different technologies. Although these vaccines target the isolates collected early in the pandemic, many have protected against serious illness from newer variants.
Puthupparampil V. Scaria   +9 more
doaj   +1 more source

Consensus recommendation for meningococcal disease prevention in children and adolescents in the Middle East region

open access: yesJournal of Epidemiology and Global Health, 2019
Facing the availability of the new generation of quadrivalent meningococcal conjugate vaccines (Menveo®, Menactra® and others pending for license) and their recent implementation in Saudi Arabia, experts from 11 countries of the Middle East region met at
Atef Shibl   +4 more
doaj   +1 more source

Adesão às novas vacinas conjugadas. Vacina anti-meningocócica e anti-pneumocócica.

open access: yesActa Médica Portuguesa, 2004
The new conjugate vaccines against group C meningococcal infection and pneumococcal infection were introduced in Portugal in 2001. In 2001/2002, the media published several alarming news on meningococcal disease and there was an increased demand of those
Laurinda De Queirós   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy